Association Between CRSA and OSA

NCT04634786 | Unknown

• 1 other identifier: 2020-A02305-34
• Study Type: observational
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

This goal of this study is to know the association between the central serous chorioretinopathy and the obstructive sleep apnea. Many studies have been done in order to assess the association between the central serous chorioretinopathy and obstructive sleep apnea and the results are always controverses actually.

Conditions

Chorioretinopathy; Obstructive Sleep Apnea

Outcome Measures

Primary Outcomes (1)

• Association between central serous chorioretinopathy and the obstructive sleep apnea.

  Percentage of high risks of obstructive sleep apnea in patients affected by central serous chorioretinopathy in using the Berlin survey. The Berlin questions include 3 categories: The category 1 is positive if 2 answers are positive. The category 2 is positive if 2 answers are positive. The category 3 is positive if 1 answer is positive. Finally, if 2 categories are positive, the patient is considered as high risk of obstructive sleep apnea.

  During 3 months we will collect the results of Berlin survey.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The central serous chorioretinopathy is defined by RSD (retinal serous detachment) located to the macula, it must be diagnosed since 6 months. Patients with central serous chorioretinopathy will undergo a Berlin Questions to assess the risks to have an obstructive sleep apnea. More over, we measure the choroid's thickness by using EDI OCT(Enhanced depth imaging optical coherence tomography) The survey and the measure of the choroid's thickness will be performed during an ophthalmology routing consultation.

You may qualify if:

• Central serous chorioretinopathy since 6 months at least
• Patients beyond 18 years old

You may not qualify if:

• \- All retina pathology will be excluded : diabetes with affected retina, maculopathy, retina central veinous oclusion, epithéliopathy

Sponsors & Collaborators

• Poitiers University Hospital: lead

Study Sites (1)

CHU de Poitiers

Poitiers, France

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea Syndromes; Apnea; Respiration Disorders; Respiratory Tract Diseases; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases

Central Study Contacts

Nicolas LEVEZIEL, Pr

CONTACT

0549444182; nicolas.leveziel@chu-poitiers.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 12, 2020
• First Posted: November 18, 2020
• Study Start: February 6, 2021
• Primary Completion: August 6, 2021
• Study Completion: August 6, 2021
• Last Updated: April 19, 2021

Record last verified: 2021-04

Locations

FR (1)